Update on Adjustable Trans-Obturator Male System (ATOMS) for Male Incontinence after Prostate Cancer Surgery.
adjustable trans-obturator male system
artificial urinary sphincter
effectiveness
post-prostatectomy incontinence
prostate cancer
safety
Journal
Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503
Informations de publication
Date de publication:
12 04 2023
12 04 2023
Historique:
received:
10
02
2023
revised:
03
04
2023
accepted:
10
04
2023
medline:
17
5
2023
pubmed:
15
5
2023
entrez:
15
5
2023
Statut:
epublish
Résumé
(1) Background: The adjustable trans-obturator male system (ATOMS) is a surgical device developed to treat post-prostatectomy incontinence (PPI) after prostate cancer treatment. We review the current literature on this anti-incontinence device with the intention of assessing the effectiveness, safety and duration of the silicone-covered scrotal port (SSP) ATOMS, the only generation of the device that is currently available. (2) Material and Methods: Non-systematic literature review is performed. Forty-eight full-text articles are assessed for eligibility. Case reports, expert opinions or commentaries without specific data reported (
Identifiants
pubmed: 37185429
pii: curroncol30040316
doi: 10.3390/curroncol30040316
pmc: PMC10136884
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
4153-4165Références
Adv Ther. 2017 May;34(5):1173-1183
pubmed: 28405960
Prostate Cancer Prostatic Dis. 2022 Jun 21;:
pubmed: 35729329
World J Urol. 2017 Jan;35(1):145-151
pubmed: 27156092
Neurourol Urodyn. 2019 Feb;38(2):710-718
pubmed: 30575997
Neurourol Urodyn. 2020 Aug;39(6):1746-1752
pubmed: 32496612
Adv Urol. 2012;2012:835290
pubmed: 22536227
Int Braz J Urol. 2021 Nov-Dec;47(6):1131-1135
pubmed: 33861057
Minerva Urol Nefrol. 2020 Dec;72(6):770-777
pubmed: 31692302
BJU Int. 2015 Feb;115(2):300-7
pubmed: 24731208
Int J Impot Res. 2021 Sep;33(6):577-582
pubmed: 32499613
Front Surg. 2022 Feb 14;9:825239
pubmed: 35237650
Can Urol Assoc J. 2022 May;16(5):E256-E260
pubmed: 34941490
World J Urol. 2019 Aug;37(8):1679-1686
pubmed: 30377812
Adv Ther. 2021 Jan;38(1):678-690
pubmed: 33230712
J Clin Med. 2022 Aug 19;11(16):
pubmed: 36013121
Urology. 2016 Apr;90:189-94
pubmed: 26773347
Int Braz J Urol. 2021 Mar-Apr;47(2):423-425
pubmed: 33284546
PLoS One. 2019 Dec 2;14(12):e0225762
pubmed: 31790490
Urol Int. 2018;101(1):106-113
pubmed: 29953998
Actas Urol Esp (Engl Ed). 2018 Sep;42(7):473-482
pubmed: 29642999
World J Urol. 2019 Oct;37(10):2189-2197
pubmed: 30649591
J Urol. 2012 Mar;187(3):956-61
pubmed: 22264469
J Pers Med. 2022 Jan 12;12(1):
pubmed: 35055409
Health Technol Assess. 2022 Aug;26(36):1-152
pubmed: 35972773
World J Urol. 2020 Jul;38(7):1795-1803
pubmed: 31542824
Urology. 2021 Nov;157:120-127
pubmed: 34425151
Int Urol Nephrol. 2016 Oct;48(10):1571-6
pubmed: 27417131
Transl Androl Urol. 2017 Jul;6(Suppl 2):S112-S121
pubmed: 28791230
Eur Urol. 2013 Apr;63(4):681-9
pubmed: 23219375
Neurourol Urodyn. 2021 Jun;40(5):1089-1097
pubmed: 33851426
J Urol. 2019 Nov;202(5):1022-1028
pubmed: 31251715
Urology. 2021 Feb;148:280-286
pubmed: 33181122
Front Surg. 2021 Apr 09;8:647656
pubmed: 33898508
J Basic Clin Physiol Pharmacol. 2022 Apr 07;34(1):49-54
pubmed: 35390245
Neurourol Urodyn. 2020 Aug;39(6):1737-1745
pubmed: 32496606
Transl Androl Urol. 2022 Aug;11(8):1200-1209
pubmed: 36092846
J Clin Med. 2021 Dec 24;11(1):
pubmed: 35011821
Adv Ther. 2019 Feb;36(2):426-441
pubmed: 30560525
J Clin Med. 2023 Mar 15;12(6):
pubmed: 36983297
Urology. 2015 Sep;86(3):602-7
pubmed: 26135815
Neurourol Urodyn. 2021 Mar;40(3):897-909
pubmed: 33645867
Neurourol Urodyn. 2022 Feb;41(2):609-615
pubmed: 34969148
World J Urol. 2021 Apr;39(4):1083-1092
pubmed: 32529450
BJU Int. 2017 May;119(5):785-792
pubmed: 27868328
BJU Int. 2006 Jun;97(6):1234-41
pubmed: 16686718
Neurourol Urodyn. 2018 Apr;37(4):1458-1466
pubmed: 29315765
Eur Urol Focus. 2016 Aug;2(3):245-259
pubmed: 28723370
BJU Int. 2005 Jun;95(9):1364-6
pubmed: 15892832
Actas Urol Esp (Engl Ed). 2018 May;42(4):267-272
pubmed: 29174630